Saltar al contenido
Merck

Pyrazinoic acid decreases the proton motive force, respiratory ATP synthesis activity, and cellular ATP levels.

Antimicrobial agents and chemotherapy (2011-08-31)
Ping Lu, Anna C Haagsma, Hoang Pham, Janneke J Maaskant, Selena Mol, Holger Lill, Dirk Bald
RESUMEN

Pyrazinoic acid, the active form of the first-line antituberculosis drug pyrazinamide, decreased the proton motive force and respiratory ATP synthesis rates in subcellular mycobacterial membrane assays. Pyrazinoic acid also significantly lowered cellular ATP levels in Mycobacterium bovis BCG. These results indicate that the predominant mechanism of killing by this drug may operate by depletion of cellular ATP reserves.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Pyrazinecarboxylic acid, 99%